Romofab Holding ApS: Financial statements 2019
CVR: 38556797
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Romofab Holding ApS (CVR 38556797) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -15,000 and a net result of DKK -18,209 compared with DKK -12,000 the year before. Equity in the 2019 report amounted to DKK 453,666. The solvency ratio was 90.7%.
- Gross Profit
- DKK -15,000
- Profit/Loss
- DKK -18,209
- Equity
- DKK 453,666
- Total Assets
- DKK 500,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -15 t. | -18 t. | 454 t. | - |
| 2018 | - | -12 t. | -12 t. | 472 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Romofab Holding ApS has published its annual report for 2018. Gross profit came to DKK -12,000, and the net result was DKK -12,000.
About Romofab Holding ApS
Romofab Holding ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Molly Bilde Fabrin and Robert Fabrin. The company is owned by Robert Fabrin and Molly Bilde Fabrin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,750 and a net result of DKK 284,766 compared with DKK -2,029,900 the year before. Equity in the 2025 report amounted to DKK -1,399,345.